GSK3βhigh/NFATc1high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Targeting the GSK3βhigh/NFATc1high Subtype to Overcome Therapy Resistance in Pancreatic Cancer via Induction of Homologous Recombination Repair Mechanisms

  • By

  • Muhammad Umair Latif

  • Xueang Liu

  • Aiko Bockelmann

  • Laura Huhnold

  • Geske Elisabeth Schmidt

  • Lukas Klein

  • Xueyuan Zhao

  • Lena-Christin Conradi

  • Karly Conrads

  • Anna Lena Weber

  • Sercan Mercan

  • Kristina Reutlinger

  • Atmika Paul

  • Zeynab Najafova

  • Steven A Johnsen

  • Zuriñe Bonilla Del Rio

  • Frederike Penz

  • Jovan Todorovic

  • Holger Bastians

  • Tim Beissbarth

  • Ulrich Sax

  • Ramy Ashry

  • Oliver H Krämer

  • Elisabeth Hessmann

  • Günter Schneider

  • Philipp Stroebel

  • Ivan Bogeski

  • Shiv K Singh

  • Volker Ellenrieder

  • August 1, 2026

Share

Original Source(s)

Related Content